Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study
Cathrine Goberg Olsen(University of Oslo), Helle Høyer(Telemark Hospital), Unn Ljøstad(Sørlandet Sykehus), Øystein L. Holla(Telemark Hospital), Helene Ballo Kvernmo(Norwegian University of Science and Technology), Ola Nakken(Akershus University Hospital), Margitta T. Kampman(University Hospital of North Norway), Karl Bjørnar Alstadhaug(Nordland Hospital Trust), Kristian Tveten(Telemark Hospital), Ole‐Bjørn Tysnes(Haukeland University Hospital), Camilla Novy(University of Oslo), Geir J. Braathen(Telemark Hospital), Grethe Kleveland(Innlandet Hospital Trust), Tiina Rekand(Haukeland University Hospital), Angelina Maniaol(Oslo University Hospital), Åse Hagen Morsund(Molde Hospital), Øyvind L. Busk(Telemark Hospital), Erika Hallerstig(Østfold Hospital Trust), Tori Navestad Aanjesen(Akershus University Hospital), Trygve Holmøy(OsloMet – Oslo Metropolitan University), Natasha Demic(Sykehuset i Vestfold), Heidi Øyen Flemmen(Telemark Hospital), Anne Berit Jøntvedt(Telemark Hospital), Kristin Lif Breivik(Helse Førde), Ingrid Kristine Bjørnå(Vestre Viken Hospital Trust), Stephan Schüler(Namsos Hospital), Ineke Hogenesch(Privatsykehuset Haugesund)
Cited by 21
Related Papers
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
|The American Journal of Human Genetics|2017|202
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry
|European Heart Journal|2019|188
Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom
|Annals of Neurology|2016|125
Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies
|Genetics in Medicine|2018|91
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
|Multiple Sclerosis Journal|2015|76